Jun 6, 2013 | Recent Deals | Silicon Valley
O’Melveny & Myers LLP represented Celsion Corporation in its registered direct offering of approximately US$9.83 million of the Company’s common stock to institutional investors led by a health care fund. The offering is subject to customary closing conditions.
The O’Melveny team included Jennifer DePalma, Ruchun Ji, and Sam Zucker.
Related Posts:
- O’Melveny Represents Dicerna Pharmaceuticals in US$60 Million Private Financing Transaction
- O’Melveny Represents Celsion Corporation in a US$15 Million Private Placement
- O’Melveny Represents Investors in US$40 Million Series A Convertible Preferred Stock Financing with Alimera Sciences
- O’Melveny Represents Progenics Pharmaceuticals in Proposed Public Offering
- O’Melveny Represents Cytomx Therapeutics in Expansion of Series B Financing